Table 3.
Vaccine coverage
| Vaccines | <2 yrs | 2-17 yrs | 18-59 yrs | ≥60 yrs | All ages | |
|---|---|---|---|---|---|---|
| |
PCV7 |
23 (49%) |
18 (36%) |
19 (17.0%) |
10 (29%) |
70 (28.7%) |
| |
PCV10 |
28 (60%) |
29 (58%) |
50 (44.6%) |
21 (60%) |
128 (52.5%) |
| |
PCV13 |
32 (68%) |
35 (70%) |
63 (56.2%) |
27 (77%) |
157 (64.3%) |
| |
PCV15* |
33 (70%) |
37 (74%) |
64 (57.1%) |
28 (80%) |
162 (66.4%) |
| |
PPV23** |
33 (70%) |
41 (82%) |
75 (67.0%) |
29 (83%) |
178 (73.0%) |
| Total | 47 | 50 | 112 | 35 | 244 |
Number (percent) of strains covered by PCV-7, -10, -13, the coming PCV15 and the PPV23 in different age groups and all ages. N=244 *PCV15 includes all PCV13 serotypes, 22 F and 33 F. **Pneumococcal polysaccharide vaccine 23, includes serotypes 1, 2, 3, 4, 5, 6B, 7 F, 8, 9 N, 9 V, 10A, 11A, 12 F, 14, 15B, 17 F, 18C, 19A, 19 F, 20, 22 F, 23 F, 33 F.